Cargando…
Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1)
The expression of the drug efflux pump ABCB1 correlates negatively with cancer survival, making the transporter an attractive target for therapeutic inhibition. In order to identify new inhibitors of ABCB1, we have exploited the cryo-EM structure of the protein to develop a pharmacophore model deriv...
Autores principales: | Cheema, Yasmeen, Kiani, Yusra Sajid, Linton, Kenneth J., Jabeen, Ishrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049699/ https://www.ncbi.nlm.nih.gov/pubmed/36982374 http://dx.doi.org/10.3390/ijms24065298 |
Ejemplares similares
-
Lipophilic Metabolic
Efficiency (LipMetE) and Drug
Efficiency Indices to Explore the Metabolic Properties of the Substrates
of Selected Cytochrome P450 Isoforms
por: Kiani, Yusra Sajid, et al.
Publicado: (2019) -
Structure–Activity
Relationships, Ligand Efficiency,
and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors
of the Multidrug Transporter P-Glycoprotein
por: Jabeen, Ishrat, et al.
Publicado: (2012) -
Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors
por: Kiani, Yusra Sajid, et al.
Publicado: (2019) -
The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter
por: Ding, Pei-Rong, et al.
Publicado: (2011) -
The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance
por: Duran, George E., et al.
Publicado: (2019)